Symbols / BCAR Stock $10.22 -0.20% D. Boral ARC Acquisition I Corp.
BCAR (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
D. Boral ARC Acquisition I Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York. D.
Ratings
Current target
$10.22
Low
—
High
—
Mean
—
- BCAR SEC Filings - D. Boral Arc Acq I Corp. 10-K, 10-Q, 8-K Forms - Stock Titan hu, 30 Apr 2026 04
- Merger agreement signed as BCAR (NASDAQ: BCAR) files Form S-4 for Exascale deal - Stock Titan Wed, 29 Apr 2026 10
- symbol__ Stock Quote Price and Forecast - CNN Wed, 20 Aug 2025 14
- BCAR Stock Price and Chart — NASDAQ:BCAR - TradingView Wed, 20 Aug 2025 18
- Is Boral ARC (BCAR) Stock Lagging the Market | Price at $10.12, Up 0.05% - Community Trade Ideas - Cổng thông tin điện tử Tỉnh Sơn La Fri, 10 Apr 2026 07
- D. BORAL ARC ACQUISIT - CL A (BCAR) Fundamental Analysis & Valuation - ChartMill Sun, 09 Nov 2025 22
- Exascale Labs–BCAR (NASDAQ: BCAR) SPAC deal sets $500M valuation - Stock Titan Wed, 29 Apr 2026 10
- D. Boral ARC Acquisition I Signs Multiple Material Agreements - TradingView ue, 13 Jan 2026 08
- D. Boral ARC Acquisition I Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing August 20, 2025 - Yahoo Finance ue, 19 Aug 2025 07
- The trading volume of these stocks is deviating from the norm in today's session. - ChartMill Wed, 21 Jan 2026 08
- Exascale Labs Inc. to Combine with D. Boral ARC Acquisition I Corp. - ARC Group Mon, 12 Jan 2026 08
- Nuveen (QQQX) Stock: Should You Start a Position | - Pro Trader Recommendations - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 03
- Is Plexus (PLXS) Stock Undervalued Now | Price at $217.70, Up 4.73% - Trending Volume Leaders - Cổng thông tin điện tử Tỉnh Sơn La Wed, 08 Apr 2026 07
- Context Capital Management, LLC - Portfolio Stock Holdings - Quiver Quantitative Wed, 31 Dec 2025 08
- Blood industry bonds together to solidify cell and gene manufacturing and commercialization - BioProcess International Wed, 08 Jan 2025 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
No income statement data available.
| Line Item | Trend | 2025-12-31 |
|---|---|---|
| Total Assets |
|
285.40
|
| Current Assets |
|
0.62
|
| Cash Cash Equivalents And Short Term Investments |
|
0.42
|
| Cash And Cash Equivalents |
|
0.42
|
| Cash Financial |
|
0.42
|
| Prepaid Assets |
|
0.20
|
| Total Non Current Assets |
|
284.78
|
| Other Non Current Assets |
|
284.78
|
| Total Liabilities Net Minority Interest |
|
0.04
|
| Current Liabilities |
|
0.04
|
| Payables And Accrued Expenses |
|
0.04
|
| Current Accrued Expenses |
|
0.04
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
| Stockholders Equity |
|
285.36
|
| Common Stock Equity |
|
285.36
|
| Capital Stock |
|
284.78
|
| Common Stock |
|
284.78
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
41.20
|
| Ordinary Shares Number |
|
41.20
|
| Additional Paid In Capital |
|
0.00
|
| Retained Earnings |
|
0.58
|
| Total Equity Gross Minority Interest |
|
285.36
|
| Total Capitalization |
|
285.36
|
| Working Capital |
|
0.59
|
| Invested Capital |
|
285.36
|
| Net Tangible Assets |
|
285.36
|
| Tangible Book Value |
|
285.36
|
No cash flow data available.
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|